Skip to main content
Clinical Trials/NL-OMON43957
NL-OMON43957
Completed
Not Applicable

Health-related quality of life, disease burden and cognition in meningioma patients and their informal caregivers - Disease burden in meningioma patients and their informal caregivers

Vrije Universiteit Medisch Centrum0 sites400 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
meningioma
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
400
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) Adult patients, must be over 18 years old;
  • (2\) Patients with a histologically confirmed or suspected intracranial meningioma;
  • (3\) The end of the primary anti\-tumor treatment was at least 5 years prior to inclusion. ;Every participant will be asked if there is an informal caregiver available to participate as well. They are:
  • (1\) Adults; over 18 years old;
  • (2\) The spouse, family member, or close friend of the patient;
  • (3\) They provide the majority of emotional and physical support to the patient.

Exclusion Criteria

  • (1\) Currently receiving anti\-tumor treatment;
  • (2\) Having received whole\-brain radiation for a disease other than a confirmed or suspected intracranial meningioma;
  • (3\) Diagnosed with neurofibromatosis type 2;
  • (4\) Diagnosed with a neurodegenerative disease influencing their cognitive abilities;
  • (5\) Incompetent and not having a legal representative to provide consent to study participation on their behalf;
  • (6\) Insufficient understanding of the Dutch language;
  • (7\) Not signed informed consent.;Informal caregivers:
  • (1\) Insufficient understanding of the Dutch language;
  • (2\) Diagnosed with a neurodegenerative disease influencing their cognitive abilities;
  • (3\) The patient does not sign informed consent;

Outcomes

Primary Outcomes

Not specified

Similar Trials